Novartis, U.S. partner plan remote trials to boost participation

ZURICH (Reuters) - Novartis plans up to 10 clinical trials over three years using a U.S. partner's mobile technology to help free patients from burdensome hospital trips as the Swiss drugmaker aims to boost study participation and cut costs.

U.S. sailors visit Vietnamese shelter for victims of Agent Orange

DANANG, Vietnam (Reuters) - Sailors from a U.S. aircraft carrier on Wednesday visited a Vietnamese shelter for people suffering from the effects of Agent Orange, a chemical used by the U.S. military during the Vietnam War to destroy foliage.

South Africa's popular sandwich shops bear brunt of listeria scare

SOWETO, South Africa (Reuters) - As South Africa grapples with the world's worst listeria outbreak, it is small mom-and-pop stores that dot places like the black township of Soweto that are taking a financial hit as customers fear for their lives.

Mississippi lawmakers approve ban on abortions after 15 weeks

(Reuters) - Mississippi lawmakers have approved a measure banning abortion after 15 weeks of gestation, moving the state a step closer to enacting the United States' most restrictive abortion law, the lieutenant governor said on Tuesday.

U.S. FDA allows 23andMe to sell test for 3 mutations of breast cancer gene

(Reuters) - The U.S. Food and Drug Administration on Tuesday allowed genetic testing company 23andMe to market directly to consumers its test that will help assess three mutations in a common type of breast cancer gene.

Opioids no better than NSAIDs for chronic back or arthritis pain

(Reuters Health) - Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests.

H1N1 swine flu kills one in Hungary: MTI agency

BUDAPEST (Reuters) - A man has died of the H1N1 flu virus in a hospital in Hungary, national news agency MTI said on Tuesday, quoting regional daily Eszak-Magyarorszag.

Israeli healthcare startup Medial EarlySign raises $30 million

TEL AVIV (Reuters) - Israel's Medial EarlySign, whose machine-learning based technology is meant to help improve patient management, said on Tuesday it raised $30 million, bringing its total funding to $50 million.

FDA approves new dosing for Bristol-Myers Squibb's Opdivo

(Reuters) - Bristol-Myers Squibb Co said on Tuesday the U.S. Food and Drug Administration had approved a four-week dosing schedule for its cancer drug, Opdivo.

Argentina lawmakers present bill to legalize abortion

BUENOS AIRES (Reuters) - Dozens of Argentine lawmakers of all political stripes presented a bill to legalize abortion on Tuesday, launching a debate that promised to divide a deeply Catholic nation.

Related Videos

Whalecam reveals secrets of Antarctic minke

Hybrid bee at the heart of UAE sustainable honey plan

Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app